Crystallographic identification of a noncompetitive inhibitor binding site on the hepatitis C virus NS5B RNA polymerase enzyme

被引:143
|
作者
Love, RA [1 ]
Parge, HE [1 ]
Yu, X [1 ]
Hickey, MJ [1 ]
Diehl, W [1 ]
Gao, JJ [1 ]
Wriggers, H [1 ]
Ekker, A [1 ]
Wang, LA [1 ]
Thomson, JA [1 ]
Dragovich, PS [1 ]
Fuhrman, SA [1 ]
机构
[1] Pfizer Global Res & Dev, La Jolla Labs, San Diego, CA 92121 USA
关键词
D O I
10.1128/JVI.77.13.7575-7581.2003
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The virus-encoded nonstructural protein 5B (NS5B) of hepatitis C virus (HCV) is an RNA-dependent RNA polymerase and is absolutely required for replication of the virus. NS5B exhibits significant differences from cellular polymerases and therefore has become an attractive target for anti-HCV therapy. Using a high-throughput screen, we discovered a novel NS5B inhibitor that binds to the enzyme noncompetitively with respect to nucleotide substrates. Here we report the crystal structure of NS5B complexed with this small molecule inhibitor. Unexpectedly, the inhibitor is bound within a narrow cleft on the protein's surface in the "thumb" domain, about 30 Angstrom from the enzyme's catalytic center. The interaction between this inhibitor and NS5B occurs without dramatic changes to the structure of the protein, and sequence analysis suggests that the binding site is conserved across known HCV genotypes. Possible mechanisms of inhibition include perturbation of protein dynamics, interference with RNA binding, and disruption of enzyme oligomerization.
引用
收藏
页码:7575 / 7581
页数:7
相关论文
共 50 条
  • [1] Crystallographic identification of a noncompetitive inhibitor binding site on the hepatitis C virus NS5B RNA polymerase enzyme (vol 77, pg 7575, 2003)
    Love, RA
    Parge, HE
    Yu, X
    Hickey, MJ
    Diehl, W
    Gao, JJ
    Wriggers, H
    Ekker, A
    Wang, L
    Thomson, JA
    Dragovich, PS
    Fuhrman, SA
    JOURNAL OF VIROLOGY, 2003, 77 (18) : 10176 - 10176
  • [2] PHARMACOPHORE DEVELOPMENT & EXPLORATION OF THE BINDING SITE OF HEPATITIS C VIRUS NS5B RNA POLYMERASE INHIBITOR
    Telvekar, Vikas N.
    Patel, Kavitkumar N.
    MEDICINAL CHEMISTRY RESEARCH, 2010, 19 : S76 - S77
  • [3] Hepatitis C virus RNA-dependent RNA polymerase (NS5B polymerase)
    Hagedorn, CH
    van Beers, EH
    De Staercke, C
    HEPATITIS C VIRUSES, 2000, 242 : 225 - 260
  • [4] Formal Synthesis of Hepatitis C Virus NS5B Polymerase Inhibitor
    Noro, Takahiro
    Okano, Kentaro
    Tokuyama, Hidetoshi
    SYNLETT, 2013, 24 (16) : 2143 - 2147
  • [6] Inhibitors of the Hepatitis C Virus RNA-Dependent RNA Polymerase NS5B
    Powdrill, Megan H.
    Bernatchez, Jean A.
    Goette, Matthias
    VIRUSES-BASEL, 2010, 2 (10): : 2169 - 2195
  • [7] Expressed hepatitis C virus NS5b RNA polymerase is a non-processive enzyme.
    Chung, RT
    Han, CJ
    Kaplan, LM
    GASTROENTEROLOGY, 1997, 112 (04) : A1244 - A1244
  • [8] Elongation of synthetic RNA templates by hepatitis C virus NS5B polymerase
    Liu, CH
    Chopra, R
    Swanberg, S
    Olland, S
    O'Connell, J
    Herrmann, S
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (11) : 10738 - 10746
  • [9] Expression of hepatitis C virus NS5B protein: Characterization of its RNA polymerase activity and RNA binding
    Ishii, K
    Tanaka, Y
    Yap, CC
    Aizaki, H
    Matsuura, Y
    Miyamura, T
    HEPATOLOGY, 1999, 29 (04) : 1227 - 1235
  • [10] Valopicitabine -: Anti-hepatitis C virus drug RNA-directed RNA polymerase (NS5B) inhibitor
    Sorbera, L. A.
    Castaner, J.
    Leeson, P. A.
    DRUGS OF THE FUTURE, 2006, 31 (04) : 320 - 324